BiomeBank has raised $10.7m to fast-track Crohn’s disease treatment

ADELAIDE: BiomeBank has raised $10.65m with the Adelaide-based biotechnology company to use the ... read more

Cochlear acquisition deal sparks ACCC competition concerns

MELBOURNE: Cochlear’s proposed $170 million acquisition of a Danish hearing loss device maker ... read more

Healius dives as Covid-19 boom times end for pathology giants

MELBOURNE: Healius shares have dived more than 10 per cent after it revealed ... read more

Virgin sends another IPO signal with return to long-haul flying

BRISBANE: Virgin Australia has launched its return to long-haul international flying with a ... read more